Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.25p
   
  • Change Today:
      0.50p
  • 52 Week High: 34.25
  • 52 Week Low: 8.90
  • Currency: UK Pounds
  • Shares Issued: 102.32m
  • Volume: 570,693
  • Market Cap: £10.49m
  • RiskGrade: 435

Latest ShareCast News

ValiRx incorporates new wholly-owned lab subsidiary

By Josh White

Date: Wednesday 01 Mar 2023

(Sharecast News) - Life science company ValiRx announced the incorporation of a new wholly-owned subsidiary, Inaphaea BioLabs, on Wednesday.

Valirx ShareCast News

ValiRx forms new majority-owned breast cancer su... 24-Oct-2022 ShareCast
ValiRx expecting to grant extension of exclusivi... 17-Jun-2022 ShareCast
ValiRx amends longstanding licence deal with Can... 20-Dec-2021 ShareCast
ValiRx adds three new patents in first half 06-Jul-2021 ShareCast
ValiRx terminates peptide drug candidate deal 27-May-2021 ShareCast

Valirx Regulatory News

Incorporation of Inaphaea BioLabs Limited 01-Mar-2023 07:00 RNS
Second Price Monitoring Extn 24-Feb-2023 16:40 RNS
Price Monitoring Extension 24-Feb-2023 16:35 RNS
Result of GM, Issue of Equity 02-Feb-2023 12:45 RNS
Operational Update 31-Jan-2023 07:02 RNS

Valirx Newspaper Links

Business Digest 24-Sep-2006 Sunday Times

Valirx Tips & Analysis

IOS acquires Indian restaurants owner 30-Jan-2008 Times
Small caps 13-Nov-2007 Times
Kelda springs to life as takeover talk bubbles up 11-Sep-2007 Telegraph
Kelda climbs on revived takeover speculation 11-Sep-2007 The Independent
Alliance & Leicester buoyed by talk of NAB bid 09-Aug-2007 The Independent

Valirx News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 10.25p
Change Today 0.50p
% Change 5.13 %
52 Week High 34.25
52 Week Low 8.90
Volume 570,693
Shares Issued 102.32m
Market Cap £10.49m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
42.59% below the market average42.59% below the market average42.59% below the market average42.59% below the market average42.59% below the market average
36.67% below the sector average36.67% below the sector average36.67% below the sector average36.67% below the sector average36.67% below the sector average
Price Trend
79.7% below the market average79.7% below the market average79.7% below the market average79.7% below the market average79.7% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Valirx Dividends

No dividends found

Trades for 27-Mar-2023

Time Volume / Share Price
16:17 19,139 @ 10.40p
15:24 20,313 @ 9.93p
15:06 927 @ 10.47p
15:06 886 @ 10.48p
15:04 28,514 @ 10.50p

Valirx Key Personnel

CFO Gerald Desler
CEO Suzanne Dilly

Top of Page